AZD4076 in Type 2 Diabetic subjects with Non-Alcoholic Fatty Liver Disease.

Trial Identifier:	D5590C00002
Sponsor:	AstraZeneca
NCTID::	NCT02826525
Start Date:	July 2016
Primary Completion Date:	October 2019
Study Completion Date:	October 2019
Condition:	Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English version
	Spanish Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.